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We  conducted  an  epidemiologic  investigation  of  an 
outbreak  of  ocular  disease  among  children  to  determine 
whether the disease was linked to Emmonsia sp., a rarely-
reported fungus and an agent of adiaspiromycosis. Using 
an  unmatched  case–control  study  design,  we  compared 
case-patients with asymptomatic controls randomly select-
ed from the population. Scleral biopsies were analyzed mi-
croscopically. Of 5,084 children examined, 99 case-patients 
were identi?  ed; mean age (+1 SD) was 11.0 ± 4.4 years. 
Symptoms included photophobia (57%), ocular pain (42%), 
and blurred vision (40%). In the multivariate analysis, risk 
factors  included  diving  in  the Araguaia  River  (odds  ratio 
5.2; 95% con?  dence interval 2.4–12.0). Microscopy iden-
ti?  ed foreign bodies consistent with adiaconidia. This out-
break probably resulted from foreign-body–type reactions 
to adiaspiromycosis conidia after initial irritation caused by 
conjunctival contact with spicules of sponges in the river. 
Symptomatic  children  responded  to  corticosteroid  treat-
ment. Adiaspiromycosis is a preventable cause of ocular 
disease in the Amazon region. 
Acute Conjunctivitis with 
Episcleritis and Anterior Uveitis 
Linked to Adiaspiromycosis 
and Freshwater Sponges, 
Amazon Region, Brazil, 2005 
Marcia O. Mendes, Mario A.P. Moraes, Ernesto I.M. Renoiner, Marta H.P. Dantas, Tatiania M. Lanzieri, 
Carlos F. Fonseca, Expedito J.A. Luna, and Douglas L. Hatch
  3 3 6   9 0 0 2   l i r p A   , 4   . o N   , 5 1   . l o V   •   d i e / v o g . c d c . w w w   •   s e s a e s i D   s u o i t c e f n I   g n i g r e m E  
Author af?  liations: Ministry of Health, Brasília, Brazil (M.O. Men-
des, E.I.M. Renoiner, M.H.P. Dantas, T.M. Lanzieri, E.J.A. Luna); 
University of Brasília, Brasília (M.A.P. Moraes); Reference Hospital 
of Augustinópolis, Augustinópolis, Brazil (C.F. Fonseca); Centers 
for Disease Control and Prevention, Atlanta, Georgia, USA (D.L. 
Hatch); and Department of Public Health, Los Angeles, California, 
USA (D.L. Hatch)
DOI: 10.3201/eid1504.081281
CME ACTIVITY
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity 
to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation
Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC 
is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit 
commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certi? cate of par-
ticipation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; 
(3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certi? cate.
Learning Objectives
Upon completion of this activity, participants will be able to:
Describe the mechanism of infection for adiaspiromycosis. • 
Identify the age group most susceptible to ocular adiaspiromycosis. • 
Describe presenting symptoms associated with ocular adiaspiromycosis. • 
Describe the frequency of ocular lesions associated with adiaspiromycosis. • 
Identify risk factors for ocular adiaspiromycosis. • 
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CME Questions
Activity Evaluation
1. Which of the following is the most likely mechanism for 
disease associated with adiaspiromycosis?
A.   Conidia invasion
B.   Immune response
C.   Allergy
D.   Fungemia
2. Which of the following is the most common age group 
reported to be infected with ocular adiaspiromycosis in the 
initial case series of 17 patients in this article?
A.   Less than 5 years
B.   5 to 15 years
C.   16 to 25 years
D.   26 to 35 years
3. Which of the following is least likely to be reported as 
an ocular-related symptom in patients with ocular disease 
associated with adiaspiromycosis?
A.   Conjunctival hyperemia
B.   Photophobia
C.   Blurred vision
D.   Excessive tearing
4. Which of the following best describes the frequency of 
bilateral corneal opacities in patients with conﬁ  rmed ocular 
disease in this case series?
A.   13%
B.   20%
C.   35%
D.   80%
4. Which of the following is least likely to be a risk factor 
associated with ocular adiaspiromycosis in this case series?
A.   Diving in the Araguaia River
B.   Fishing in the Araguaia River
C.  Male gender
D.   Drinking Araguaia River water
1. The activity supported the learning objectives. 
Strongly Disagree Strongly Agree 
1 5 4 3 2
2. The material was organized clearly for learning to occur.
Strongly Disagree Strongly Agree
5 4 3 2 1
3. The content learned from this activity will impact my practice.
Strongly Disagree Strongly Agree
5 4 3 2 1
4. The activity was presented objectively and free of commercial bias.
Strongly Disagree Strongly Agree
5 4 3 2 1
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